Stay updated on TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The Publications section was updated to replace the TAGS Lancet Oncol 2018 paper citation with the version that includes the erratum. The prior non-erratum citation was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-10T00:17:20.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added locations across the US (Arizona, California, Florida, Illinois, Kentucky, Michigan, New Hampshire, New York, North Carolina, Pennsylvania, Rhode Island, Texas, Wisconsin) and international sites (Bavaria, Chiba, Gunma, Ibaraki, Osaka, Tochigi, Toyama, Porto District, Setúbal District, Dolj, Middlesex, Scotland), and removed several previously listed locations along with the HHS Vulnerability Disclosure link.
    Difference
    1%
    Check dated 2025-12-19T12:56:32.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page footer revision label was updated from v3.3.1 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-28T06:45:52.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The Publications section now states that entries are automatically filled from PubMed with Revision: v3.3.1, replacing the previous wording about PubMed-generated lists (Revision: v3.2.0).
    Difference
    0.0%
    Check dated 2025-11-21T01:53:35.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The government funding notice warning was removed from the page. This note previously warned that information might not be up to date and inquiries could be delayed during funding lapses.
    Difference
    0.2%
    Check dated 2025-11-13T22:28:12.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The screenshots indicate only minor UI/layout refinements with no changes to core study content, such as objectives, eligibility, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-30T13:12:28.000Z thumbnail image

Stay in the know with updates to TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page.